检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:蒋恒波[1,2] 贺正希[3] 杨红霞[2] 莫龙[4]
机构地区:[1]永州职业技术学院附属医院心内科,湖南永州425006 [2]永州职业技术学院医学院 [3]南华大学医学院 [4]中南大学湘雅医院心内科
出 处:《中南医学科学杂志》2011年第5期531-534,共4页Medical Science Journal of Central South China
摘 要:目的探讨冠心病(CHD)患者血清血管内皮生长因子(VEGF)、内抑素(ENS)水平的变化及其在CHD中的意义。方法将130例CHD患者分为急性心肌梗死组(AMI组)(42例)、不稳定型心绞痛组(UAP组)(48例)和稳定型心绞痛组(SAP组)(40例),另设对照组(36例)。采用酶联免疫吸附法(ELISA法)测定所有入选对象血清VEGF和ENS水平。结果与SAP组和对照组比较,AMI组和UAP组VEGF、ENS水平明显增高(P<0.05);AMI组VEGF、ENS水平明显高于UAP组(P<0.05);与对照组比较,SAP组VEGF、ENS水平有增高,但差异无显著性。AMI患者在第1、7和28天血清VEGF、ENS水平均高于对照组(P<0.01),第7天和28天血清VEGF、ENS水平明显高于第1天(P<0.01)。结论 CHD患者心肌缺血越严重,血清VEGF与ENS水平越高,两种因子在CHD发展过程中均有重要意义。Objective To investigate the. series changes of serum vascular endothelial growth factor(VEGF) and endostatin(ENS) level and their clinical significance in patients with coronary heart disease(CHD). Methods 130 patients with CHD were divided into unstable angina pectoris(UAP) group (48 eases), acute myocardial infarction (AMI) group (42 cases) and stable angina pectoris (SAP) group (40 cases). In addition,36 healthy cases were used as control group. The serum level of VEGF and ENS in all the eases were tested by enzyme-linked immunosorbent assay (ELISA). Results Compared with control group,the levels of VEGF and ENS in AMI and UAP group were much higher (P 〈0.05). Compared with UAP group,the levels of VEGF and ENS in AMI group were higher (P 〈0. 05). However,there was no difference between SAP and control group (P 〉 0.05). Compared with control group,the levels of VEGF and ENS in AMI at day 1,7,28 were much higher,and the levels of VEGF and ENS at day 7,28 were much higher than thoes at day 1. Conclusion The more severe CHD was,the higher level of serum VEGF and ENS were. Both VEGF and ENS play an important role in the development of CHD.
分 类 号:R541.4[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.117.197.188